Siew Ng is Professor at the Department of Medicine and Therapeutics, Assistant Dean (Development) and Associate Director for Centre for Gut Microbiota Research, The Chinese University of Hong Kong. She graduated from St Bartholomew’s and Royal London School of Medicine and was awarded Doctor of Philosophy degree from Imperial College London.  Her main research interests include development of microbial diagnostics and innovative applications of microbial medicine for inflammatory bowel disease, obesity and cancer. She has published 200 scientific articles in Nature Genetics, Nature Communications, Lancet and has filed several patents. She is pioneer of a 100K mother-baby cohort in Greater Bay area, China. As a world-renowned clinician-scientist, she received many International awards including Sir David Todd Lectureship, Sir Frances Avery Jones Lectureship, First-class Higher Education Outstanding Scientific Research Output Award and Emerging Leader Lectureship Award. In 2017, she established Asia’s First Microbiota Transplantation & Research Centre to develop personalized gut microbiota-based therapy. Her center is the sole provider of FMT to the health authority in Hong Kong. Recently, she received a prestigious grant from the Innovation and Technology Commission to develop the first and only biotechnology center for microbiota in Hong Kong. She serves as Director for the Microbiota Innovation Center (M@gIC) at Hong Kong Science and Technology Park and co-founder of GenieBiome that aims to provide elite microbial screening and microbiome-based precision medicine for prevention and treatment of human diseases.